ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DENNIS SALAZAR M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,789Medicare Part D Prescriptions Filled, Including Refills

Rank: 798 out of 3647

$277K Total Retail Price of All Prescriptions

Rank: 2112 out of 3647

782 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 782 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 782 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,948 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$26 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 589 521 1 1
OMEPRAZOLE 396 331 2 3
AMLODIPINE BESYLATE 384 358 3 2
LEVOTHYROXINE SODIUM 376 333 4 5
PREDNISONE 368 313 5 43
LISINOPRIL 306 252 6 4
TEMAZEPAM 297 270 7 47
TIZANIDINE HCL 283 218 8 126
MELOXICAM 271 236 9 33
FUROSEMIDE 255 213 10 8
ALPRAZOLAM 248 176 11 31
HYDROCODONE-ACETAMINOPHEN 241 179 S3 12 12
ATENOLOL 199 193 13 10
HYDROCHLOROTHIAZIDE 187 179 14 9
METFORMIN HCL 184 163 15 6
WARFARIN SODIUM 158 142 16 15
FLUTICASONE PROPIONATE 146 116 17 32
ZOLPIDEM TARTRATE 144 88 18 14
LOSARTAN POTASSIUM 141 116 19 11
ALENDRONATE SODIUM 139 139 20 23
METOPROLOL TARTRATE 135 119 21 7
DOXAZOSIN MESYLATE 131 112 22 57
LOVASTATIN 129 112 23 21
GABAPENTIN 105 75 24 17
PRAVASTATIN SODIUM 102 100 25 16
CARVEDILOL 95 76 26 20
PAROXETINE HCL 93 86 27 60
TRAMADOL HCL 93 80 27 22
CIPROFLOXACIN HCL 87 75 29 53
POTASSIUM CHLORIDE 83 73 30 24
LORAZEPAM 79 49 31 73
FENOFIBRATE 79 45 31 50
ALLOPURINOL 78 72 33 37
DONEPEZIL HCL 77 71 34 30
RANITIDINE HCL 75 58 35 29
TRIAMTERENE-HCTZ 75 70 35 58
METOPROLOL SUCCINATE 74 72 37 18
OXYCODONE-ACETAMINOPHEN 72 52 S2 38 91
CEPHALEXIN 71 56 39 142
AZITHROMYCIN 70 55 40 34
MECLIZINE HCL 70 57 40 85
DOXYCYCLINE HYCLATE 67 50 42 145
CLOPIDOGREL 66 54 43 26
BACLOFEN 65 57 44 97
LOSARTAN-HYDROCHLOROTHIAZIDE 62 52 45 48
ENALAPRIL MALEATE 58 54 46 35
CEFADROXIL 58 48 46 519
INSULIN SYRINGE 57 26 48 76
LANTUS 55 40 49 59
OXYCODONE HCL-ACETAMINOPHEN 55 28 S2 49 104
AMOX TR-POTASSIUM CLAVULANATE 55 44 49 118
KLOR-CON 10 54 45 52 106
ADVAIR DISKUS 52 47 53 52
GLIPIZIDE 51 48 54 41
ATORVASTATIN CALCIUM 51 45 54 13
GLYBURIDE 51 51 R 54 54
PLAVIX 50 46 57 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.